🇺🇸 Cephradin in United States

FDA authorised Cephradin on 9 February 1977

Marketing authorisations

FDA — authorised 9 February 1977

  • Application: ANDA061976
  • Marketing authorisation holder: APOTHECON
  • Local brand name: VELOSEF
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA

  • Application: NDA050530
  • Marketing authorisation holder: BRISTOL MYERS SQUIBB
  • Local brand name: VELOSEF
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Other Infectious Disease approved in United States

Frequently asked questions

Is Cephradin approved in United States?

Yes. FDA authorised it on 9 February 1977; FDA has authorised it.

Who is the marketing authorisation holder for Cephradin in United States?

APOTHECON holds the US marketing authorisation.